ICICI Securities: Metropolis Healthcare Posts Decent Performance In Difficult Times

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..ICICI Securities Report.Metropolis Healthcare Ltd. has reported decent performance during difficult times aided by Covid-19 tests. Ex-Covid volumes (no. of patients) dropped 44.7% and average realisation (revenue/patient) dropped 5.2% YoY.Overall, revenue declined 29.6% YoY to Rs 1.4 billion (our estimate Rs 1.3 billion). Decline in number of tests stood at 41.7%, lower than patients drop.Ebitda margin dropped 1,860 basis points to 8.5% due to lower revenue despite sharp reduction in selling general and administrative expenses.Volumes are likely to remain muted in H1 FY21 due to lockdown but would improve Q3 FY21 onwards as situation normalises.Aggressive network expansion with business to customer focus over the past few years would help Metropolis to improve volume growth going forward..Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

ICICI Securities: Metropolis Healthcare Posts Decent Performance In Difficult Times

ICICI Securities: Metropolis Healthcare Posts Decent Performance In Difficult Times

Choose a plan